| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,508 |
11,752 |
$2.25M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,088 |
5,915 |
$1.00M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
120 |
103 |
$21K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
375 |
336 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
69 |
63 |
$14K |
| 0011A |
|
132 |
69 |
$8K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
135 |
128 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13 |
12 |
$3K |
| 0012A |
|
75 |
72 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
15 |
15 |
$3K |
| 99215 |
Prolong outpt/office vis |
15 |
14 |
$2K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
21 |
13 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
244 |
237 |
$1K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15 |
13 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
25 |
25 |
$800.40 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
14 |
12 |
$777.16 |
| 0064A |
|
13 |
13 |
$535.34 |
| 0013A |
|
12 |
12 |
$494.16 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
688 |
656 |
$165.38 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
263 |
244 |
$153.93 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
73 |
70 |
$70.18 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
19 |
19 |
$10.55 |
| 90688 |
|
27 |
27 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
16 |
15 |
$0.00 |
| 90651 |
|
14 |
13 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
13 |
13 |
$0.00 |
| 87400 |
|
28 |
28 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
59 |
52 |
$0.00 |